These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 10607764

  • 1. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
    Kokubo T, Hashizume K, Iwase H, Arai K, Tanaka A, Toma K, Hotta K, Kobayashi Y.
    Nephrol Dial Transplant; 2000 Jan; 15(1):28-33. PubMed ID: 10607764
    [Abstract] [Full Text] [Related]

  • 2. Exposed peptide core of IgA1 hinge region in IgA nephropathy.
    Kokubo T, Hiki Y, Iwase H, Tanaka A, Nishikido J, Hotta K, Kobayashi Y.
    Nephrol Dial Transplant; 1999 Jan; 14(1):81-5. PubMed ID: 10052482
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.
    Contrib Nephrol; 2007 Jan; 157():129-33. PubMed ID: 17495450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
    Yamasaki K, Suzuki H, Yasutake J, Yamazaki Y, Suzuki Y.
    Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes.
    Nakamura I, Iwase H, Arai K, Nagai Y, Toma K, Katsumata T, Hiki Y, Kokubo T, Sano T, Kobayashi Y.
    Nephrology (Carlton); 2004 Feb; 9(1):26-30. PubMed ID: 14996305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy.
    Greer MR, Barratt J, Harper SJ, Allen AC, Feehally J.
    Nephrol Dial Transplant; 1998 Aug; 13(8):1980-3. PubMed ID: 9719151
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients.
    Iwase H, Katsumata T, Itoh A, Hiki Y, Ikuko N, Sano T, Takatani T, Kobayashi Y.
    J Nephrol; 2002 Aug; 15(6):703-8. PubMed ID: 12495288
    [Abstract] [Full Text] [Related]

  • 13. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

  • 14. Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region.
    Hiki Y, Hori H, Yamamoto K, Yamamoto Y, Yuzawa Y, Kitaguchi N, Takahashi K.
    J Nephrol; 2015 Apr; 28(2):181-6. PubMed ID: 25037591
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.
    Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
    [Abstract] [Full Text] [Related]

  • 17. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y.
    J Nephrol; 2010 Mar; 23(1):70-6. PubMed ID: 20091489
    [Abstract] [Full Text] [Related]

  • 19. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.